Hi Private Rob,
I've done abit of researching around Project Twenty21 tonight and unfortunatly there hasn't been many news articles released with any updates regarding Althea or any other company for that matter. One thing i did find was the original press release from Drug Sience, the people behind the program and in which they clearly name Althea as a supplier. AGH are known to regulary post updates and keep shareholders up to date, im suprised we havent heard anything over the past couple of weeks. Fingers crossed something big is coming.
https://drugscience.org.uk/wp-content/uploads/2019/06/PRESS_RELEASE_Project_21.pdf
Jacob
Project Twenty21 News, page-16
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $8.106M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $12.01K | 587.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2447579 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 809218 | 6 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AGH (ASX) Chart |